These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30712468)

  • 1. Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Duff K; McDermott D; Luong D; Randolph C; Boxer AL
    J Clin Exp Neuropsychol; 2019 Jul; 41(5):469-475. PubMed ID: 30712468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy.
    Duff K; Randolph C; Boxer AL
    Clin Neuropsychol; 2020 Apr; 34(3):529-540. PubMed ID: 31559910
    [No Abstract]   [Full Text] [Related]  

  • 3. Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Duff K; Beglinger LJ; Theriault D; Allison J; Paulsen JS
    J Clin Exp Neuropsychol; 2010 Mar; 32(3):231-8. PubMed ID: 19484645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy.
    Sitek EJ; Konkel A; Dąbrowska M; Sławek J
    Neurol Neurochir Pol; 2015; 49(1):36-40. PubMed ID: 25666771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a cognitive composite for measuring change in progressive supranuclear palsy.
    Jaeger J; Yang L; Li Y; Castrillo-Viguera C; Haeberlein SB; Dam T; O'Gorman J
    Parkinsonism Relat Disord; 2021 Nov; 92():94-100. PubMed ID: 34736158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.
    Gerstenecker A; Mast B; Duff K; Ferman TJ; Litvan I;
    Arch Clin Neuropsychol; 2013 Mar; 28(2):104-13. PubMed ID: 23127882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.
    Brown RG; Lacomblez L; Landwehrmeyer BG; Bak T; Uttner I; Dubois B; Agid Y; Ludolph A; Bensimon G; Payan C; Leigh NP;
    Brain; 2010 Aug; 133(Pt 8):2382-93. PubMed ID: 20576697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
    Sitek EJ; Wieczorek D; Konkel A; Dąbrowska M; Sławek J
    Psychiatr Pol; 2017 Aug; 51(4):647-659. PubMed ID: 28987055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive deficits in progressive supranuclear palsy].
    Kułakowska A; Pyd E; Halicka D; Pogorzelski R; Drozdowski W
    Neurol Neurochir Pol; 2003; 37 Suppl 5():203-10. PubMed ID: 15098348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
    J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
    Assogna F; Pellicano C; Cravello L; Savini C; Macchiusi L; Pierantozzi M; Stefani A; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
    Horta-Barba A; Pagonabarraga J; Martínez-Horta S; Busteed L; Pascual-Sedano B; Illán-Gala I; Marin-Lahoz J; Aracil-Bolaños I; Pérez-Pérez J; Sampedro F; Bejr-Kasem H; Kulisevsky J
    J Neurol; 2021 Sep; 268(9):3400-3408. PubMed ID: 33704556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive dysfunction, behavioral changes and quality of life in Chinese patients with progressive supranuclear palsy.
    Ou R; Liu H; Hou Y; Wei Q; Cao B; Zhao B; Shang H
    J Neurol Sci; 2017 Sep; 380():182-186. PubMed ID: 28870563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy.
    Picillo M; Cuoco S; Carotenuto I; Abate F; Erro R; Volpe G; Pellecchia MT; Catricalà E; Cappa S; Barone P
    PLoS One; 2019; 14(10):e0223621. PubMed ID: 31603934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric disturbances in patients with progressive supranuclear palsy: a case-control study.
    Bloise MC; Berardelli I; Roselli V; Pasquini M; Stirpe P; Colosimo C; Berardelli A; Fabbrini G
    Parkinsonism Relat Disord; 2014 Sep; 20(9):965-8. PubMed ID: 24954060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.
    Ransmayr L; Fuchs A; Ransmayr-Tepser S; Kommenda R; Kögl M; Schwingenschuh P; Fellner F; Guger M; Eggers C; Darkow R; Mangesius S; Ransmayr G
    J Neural Transm (Vienna); 2022 Aug; 129(8):1039-1048. PubMed ID: 35821453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.